Targeted therapy-resistant melanoma cells acquire transcriptomic similarities with human melanoblasts

The mechanisms of adaptive and acquired drug resistance in tumors are not completely understood. So far, gene amplifications or mutations, leading to the reactivation of the MAPK or PI3K pathways have been described. In this study, we used two different methods to generate human melanoblasts: (1) vi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Larribere, Lionel (VerfasserIn) , Sachpekidis, Christos (VerfasserIn) , Hüser, Laura (VerfasserIn) , Utikal, Jochen (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 16 November 2018
In: Cancers
Year: 2018, Jahrgang: 10, Heft: 11
ISSN:2072-6694
DOI:10.3390/cancers10110451
Online-Zugang:Verlag, Volltext: https://doi.org/10.3390/cancers10110451
Verlag: https://www.mdpi.com/2072-6694/10/11/451
Volltext
Verfasserangaben:Lionel Larribère, Silke Kuphal, Christos Sachpekidis, Sachindra, Laura Hüser, Anja Bosserhoff and Jochen Utikal

MARC

LEADER 00000caa a2200000 c 4500
001 1690893737
003 DE-627
005 20220818000107.0
007 cr uuu---uuuuu
008 200225s2018 xx |||||o 00| ||eng c
024 7 |a 10.3390/cancers10110451  |2 doi 
035 |a (DE-627)1690893737 
035 |a (DE-599)KXP1690893737 
035 |a (OCoLC)1341307780 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Larribere, Lionel  |e VerfasserIn  |0 (DE-588)1118655079  |0 (DE-627)872164837  |0 (DE-576)479578648  |4 aut 
245 1 0 |a Targeted therapy-resistant melanoma cells acquire transcriptomic similarities with human melanoblasts  |c Lionel Larribère, Silke Kuphal, Christos Sachpekidis, Sachindra, Laura Hüser, Anja Bosserhoff and Jochen Utikal 
264 1 |c 16 November 2018 
300 |a 12 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 25.02.2020 
520 |a The mechanisms of adaptive and acquired drug resistance in tumors are not completely understood. So far, gene amplifications or mutations, leading to the reactivation of the MAPK or PI3K pathways have been described. In this study, we used two different methods to generate human melanoblasts: (1) via differentiation from induced pluripotent stem cells (iPSCs) and (2) via dedifferentiation from melanocytes. The melanoblast transcriptomes were then compared to the transcriptome of MAPK inhibitor-resistant melanoma cells. We observed that the expression of genes associated with cell cycle control, DNA damage control, metabolism, and cancer was altered in both melanoblast populations and in both adaptive and acquired resistant melanoma samples, compared to drug-sensitive samples. However, genes involved in antigen presentation and cellular movement were only regulated in the melanoblast populations and in the acquired resistant melanoma samples, compared to the drug-sensitive samples. Moreover, melanocyte-derived melanoblasts and adaptive resistant melanoma samples were characterized by different expression levels of certain transcription factors or genes involved in the CDK5 pathway. In conclusion, we show here that in vitro models of human melanoblasts are very important tools to comprehend the expression profiles of drug-resistant melanoma. 
650 4 |a differentiation 
650 4 |a iPSCs 
650 4 |a melanoblast 
650 4 |a melanoma 
650 4 |a resistance 
700 1 |a Sachpekidis, Christos  |d 1983-  |e VerfasserIn  |0 (DE-588)1099707269  |0 (DE-627)858738651  |0 (DE-576)469338482  |4 aut 
700 1 |a Hüser, Laura  |d 1989-  |e VerfasserIn  |0 (DE-588)1160493715  |0 (DE-627)1023730499  |0 (DE-576)505948931  |4 aut 
700 1 |a Utikal, Jochen  |d 1974-  |e VerfasserIn  |0 (DE-588)1026463750  |0 (DE-627)726765015  |0 (DE-576)371816580  |4 aut 
773 0 8 |i Enthalten in  |t Cancers  |d Basel : MDPI, 2009  |g 10(2018, 11) Artikel-Nummer 451, 12 Seiten  |h Online-Ressource  |w (DE-627)614095670  |w (DE-600)2527080-1  |w (DE-576)313958548  |x 2072-6694  |7 nnas  |a Targeted therapy-resistant melanoma cells acquire transcriptomic similarities with human melanoblasts 
773 1 8 |g volume:10  |g year:2018  |g number:11  |g extent:12  |a Targeted therapy-resistant melanoma cells acquire transcriptomic similarities with human melanoblasts 
856 4 0 |u https://doi.org/10.3390/cancers10110451  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://www.mdpi.com/2072-6694/10/11/451  |x Verlag 
951 |a AR 
992 |a 20200225 
993 |a Article 
994 |a 2018 
998 |g 1026463750  |a Utikal, Jochen  |m 1026463750:Utikal, Jochen  |d 60000  |e 60000PU1026463750  |k 0/60000/  |p 7  |y j 
998 |g 1160493715  |a Hüser, Laura  |m 1160493715:Hüser, Laura  |d 60000  |d 61900  |e 60000PH1160493715  |e 61900PH1160493715  |k 0/60000/  |k 1/60000/61900/  |p 5 
998 |g 1099707269  |a Sachpekidis, Christos  |m 1099707269:Sachpekidis, Christos  |d 50000  |e 50000PS1099707269  |k 0/50000/  |p 3 
998 |g 1118655079  |a Larribere, Lionel  |m 1118655079:Larribere, Lionel  |d 60000  |d 61900  |e 60000PL1118655079  |e 61900PL1118655079  |k 0/60000/  |k 1/60000/61900/  |p 1  |x j 
999 |a KXP-PPN1690893737  |e 3598121296 
BIB |a Y 
SER |a journal 
JSO |a {"title":[{"title_sort":"Targeted therapy-resistant melanoma cells acquire transcriptomic similarities with human melanoblasts","title":"Targeted therapy-resistant melanoma cells acquire transcriptomic similarities with human melanoblasts"}],"relHost":[{"note":["Gesehen am 27.05.2020"],"disp":"Targeted therapy-resistant melanoma cells acquire transcriptomic similarities with human melanoblastsCancers","name":{"displayForm":["Molecular Diversity Preservation International (MDPI)"]},"title":[{"title_sort":"Cancers","title":"Cancers"}],"physDesc":[{"extent":"Online-Ressource"}],"language":["eng"],"origin":[{"dateIssuedKey":"2009","publisherPlace":"Basel","publisher":"MDPI","dateIssuedDisp":"2009-"}],"recId":"614095670","part":{"year":"2018","extent":"12","volume":"10","text":"10(2018, 11) Artikel-Nummer 451, 12 Seiten","issue":"11"},"pubHistory":["1.2009 -"],"id":{"zdb":["2527080-1"],"issn":["2072-6694"],"eki":["614095670"]},"type":{"bibl":"periodical","media":"Online-Ressource"}}],"physDesc":[{"extent":"12 S."}],"id":{"eki":["1690893737"],"doi":["10.3390/cancers10110451"]},"type":{"media":"Online-Ressource","bibl":"article-journal"},"language":["eng"],"person":[{"role":"aut","display":"Larribere, Lionel","given":"Lionel","family":"Larribere"},{"given":"Christos","family":"Sachpekidis","role":"aut","display":"Sachpekidis, Christos"},{"display":"Hüser, Laura","role":"aut","family":"Hüser","given":"Laura"},{"family":"Utikal","given":"Jochen","display":"Utikal, Jochen","role":"aut"}],"origin":[{"dateIssuedDisp":"16 November 2018","dateIssuedKey":"2018"}],"note":["Gesehen am 25.02.2020"],"recId":"1690893737","name":{"displayForm":["Lionel Larribère, Silke Kuphal, Christos Sachpekidis, Sachindra, Laura Hüser, Anja Bosserhoff and Jochen Utikal"]}} 
SRT |a LARRIBERELTARGETEDTH1620